The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Leukemia, Published online: 29 July 2019; doi:10.1038/s41375-019-0529-2The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Source: Leukemia - Category: Hematology Authors: Source Type: research
More News: Hematology | Leukemia